Literature DB >> 1752595

Ofloxacin in human hair determined by high performance liquid chromatography.

N Miyazawa1, T Uematsu, A Mizuno, S Nagashima, M Nakashima.   

Abstract

A procedure is presented for quantitating ofloxacin (OFLX) in human scalp hair by high performance liquid chromatography (HPLC) with a fluorescence detector. An octadecylsilane (ODS) column was used and the mobile phase was a mixture of potassium phosphate buffer (pH 2.6) and acetonitrile. The recovery of OFLX was 90.9-93.8% and within- and between-run precisions were 0.35-1.41% and 1.41-5.49% as the coefficient of variation (CV), respectively, when 5-50 ng OFLX was added to 1 mg blank hair. The calibration curve was linear in the range of 0.5-50 ng/tube (0.5 ml). Interference with other quinolone derivatives could be avoided according to the difference in their retention times or fluorescence spectra. Several pieces of hair were obtained from each of twelve healthy male volunteers, who had taken OFLX (100, 300 or 900 mg total dose) over a 1-3 day period 2 weeks before the hair sampling. In all hair samples except one obtained from a volunteer, who had taken the lowest dose, the 2-cm long segments nearest the scalp contained OFLX (5-45 ng/mg hair), while the upper segments did not. A highly significant positive correlation was observed between the total dose and the concentration of OFLX in the 2-cm long hair segments. Such a positive correlation was also revealed in rat hair sampled after repeated i.p. administration of OFLX over a 5-week period. These results suggest that the measurement of OFLX in hair by the present method would be useful for testing patient compliance in clinical pharmacology as well as for application to forensic science.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1752595     DOI: 10.1016/0379-0738(91)90206-x

Source DB:  PubMed          Journal:  Forensic Sci Int        ISSN: 0379-0738            Impact factor:   2.395


  7 in total

1.  Comparative dispositions of ofloxacin in human head, axillary, and pubic hairs.

Authors:  K Kosuge; T Uematsu; S I Araki; H Matsuno; K Ohashi; M Nakashima
Journal:  Antimicrob Agents Chemother       Date:  1998-05       Impact factor: 5.191

Review 2.  Therapeutic drug monitoring in hair samples. Principles and practice.

Authors:  T Uematsu
Journal:  Clin Pharmacokinet       Date:  1993-08       Impact factor: 6.447

3.  Chlorpromazine in human scalp hair as an index of dosage history: comparison with simultaneously measured haloperidol.

Authors:  H Sato; T Uematsu; K Yamada; M Nakashima
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

4.  Using ofloxacin as a time marker in hair analysis for monitoring the dosage history of haloperidol.

Authors:  M Nakano; T Uematsu; H Sato; K Kosuge; M Nishimoto; M Nakashima
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

5.  The measurement of a new antimicrobial quinolone in hair as an index of drug exposure.

Authors:  T Uematsu; M Nakano; H Akiyama; M Nakashima
Journal:  Br J Clin Pharmacol       Date:  1993-02       Impact factor: 4.335

6.  Analysis of a new fluoroquinolone derivative (Q-35) in human scalp hair as an index of drug exposure and as a time marker in hair.

Authors:  T Uematsu; Y Ohsawa; A Mizuno; M Nakashima
Journal:  Int J Legal Med       Date:  1994       Impact factor: 2.686

7.  The concentration of three anti-seizure medications in hair: the effects of hair color, controlling for dose and age.

Authors:  T Mieczkowski; A M Tsatsakis; M Kruger; T Psillakis
Journal:  BMC Clin Pharmacol       Date:  2001-04-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.